Peter G. Steinherz

13.0k total citations · 1 hit paper
168 papers, 7.4k citations indexed

About

Peter G. Steinherz is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Peter G. Steinherz has authored 168 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Public Health, Environmental and Occupational Health, 84 papers in Hematology and 42 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Peter G. Steinherz's work include Acute Lymphoblastic Leukemia research (113 papers), Acute Myeloid Leukemia Research (60 papers) and Childhood Cancer Survivors' Quality of Life (38 papers). Peter G. Steinherz is often cited by papers focused on Acute Lymphoblastic Leukemia research (113 papers), Acute Myeloid Leukemia Research (60 papers) and Childhood Cancer Survivors' Quality of Life (38 papers). Peter G. Steinherz collaborates with scholars based in United States, Canada and Switzerland. Peter G. Steinherz's co-authors include Paul S. Gaynon, Harland N. Sather, James B. Nachman, Fatih M. Uckun, Gregory H. Reaman, Martha G. Sensel, Beverly J. Lange, Nyla A. Heerema, Michael E. Trigg and Laurel J. Steinherz and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Peter G. Steinherz

163 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia

2001 632 citations Peter G. Steinherz et al. Journal of Clinical Oncology profile →

Peers

Peter G. Steinherz

PHEOH

HEMAT

PPCH

ONCOL

Gary V. Dahl United States

Sima Jeha United States

Henrik Hasle Denmark

Beverly J. Lange United States

Hiroto Inaba United States

Yaddanapudi Ravindranath United States

Paul S. Gaynon United States

John T. Sandlund United States

Raymond J. Hutchinson United States

Peter F. Coccia United States

Gary V. Dahl United States

Peter G. Steinherz

2.6k ×0.6

PHEOH

2.5k ×0.7

HEMAT

1.2k ×0.5

PPCH

1.2k ×0.7

1.0k ×0.7

ONCOL

Citations per year, relative to Peter G. Steinherz Peter G. Steinherz (= 1×) peers Gary V. Dahl

Countries citing papers authored by Peter G. Steinherz

Since Specialization

Citations

This map shows the geographic impact of Peter G. Steinherz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter G. Steinherz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter G. Steinherz more than expected).

Fields of papers citing papers by Peter G. Steinherz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter G. Steinherz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter G. Steinherz. The network helps show where Peter G. Steinherz may publish in the future.

Co-authorship network of co-authors of Peter G. Steinherz

This figure shows the co-authorship network connecting the top 25 collaborators of Peter G. Steinherz. A scholar is included among the top collaborators of Peter G. Steinherz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter G. Steinherz. Peter G. Steinherz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ortiz, Michael V., Kavitha Ramaswamy, Christopher J. Forlenza, et al.. (2018). Maintenance chemotherapy to reduce the risk of a metachronous Wilms tumor in children with bilateral nephroblastomatosis. Pediatric Blood & Cancer. 66(1). e27500–e27500. 5 indexed citations

Gulati, Nitya, Farid Boulad, Maria Cancio, et al.. (2017). Brentuximab Vedotin Plus Bendamustine Is an Effective Salvage Regimen for Pediatric Patients with Relapsed Hodgkin Lymphoma. Blood. 130. 5172–5172. 1 indexed citations

Curran, Kevin J., Steven Margossian, Nancy A. Kernan, et al.. (2017). High Dose Cyclophosphamide and Pre-Treatment Disease Burden Dictate Response and Survival in a Multicenter Clinical Trial Using CD19-Specific CAR T Cells for Relapsed/Refractory B-ALL. Blood. 130. 1326–1326. 1 indexed citations

Hijiya, Nobuko, Blythe Thomson, Michael S. Isakoff, et al.. (2011). Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia. Blood. 118(23). 6043–6049. 89 indexed citations

Steinherz, Peter G., Neerav Shukla, Rachel Kobos, & Sheron Latcha. (2010). Effect of hemodialysis on the plasma levels of clofarabine. Pediatric Blood & Cancer. 55(1). 196–198. 3 indexed citations

Steinherz, Peter G., Neerav Shukla, Rachel Kobos, & Laurel J. Steinherz. (2010). Remission re‐induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia. Pediatric Blood & Cancer. 54(5). 687–693. 13 indexed citations

Jeha, Sima, Paul S. Gaynon, Bassem I. Razzouk, et al.. (2006). Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 24(12). 1917–1923. 215 indexed citations

Kolb, E. Anders, et al.. (2005). The MTOR inhibitor, rapamycin, inhibits growth of Ewing’s sarcoma in vitro and in vivo. Cancer Research. 65. 1112–1112. 1 indexed citations

Panosyan, Eduard H., Nita L. Seibel, Sagrario Martín‐Aragón, et al.. (2004). Asparaginase Antibody and Asparaginase Activity in Children With Higher-Risk Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 26(4). 217–226. 188 indexed citations

10.

Antunes, Nuno Lobo, Mark M. Souweidane, Eric Lis, Marc K. Rosenblum, & Peter G. Steinherz. (2002). Methotrexate leukoencephalopathy presenting as Klüver-Bucy syndrome and uncinate seizures. Pediatric Neurology. 26(4). 305–308. 25 indexed citations

11.

Trigg, Michael E., Peter G. Steinherz, Richard J. Chappell, et al.. (2000). Early Testicular Biopsy in Males With Acute Lymphoblastic Leukemia: Lack of Impact on Subsequent Event-Free Survival. The American journal of pediatric hematology/oncology. 22(1). 27–33. 5 indexed citations

12.

Uckun, Fatih M., James B. Nachman, Harland N. Sather, et al.. (1998). Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies. Cancer. 83(9). 2030–2039. 1 indexed citations

13.

Gaynon, Paul S., Harland N. Sather, Bruce Bostrom, et al.. (1997). Expression of BCR-ABL, E2A-PBX1, and MLL-AF4 Fusion Transcripts in Newly Diagnosed Children with Acute Lymphoblastic Leukemia: A Children's Cancer Group Initiative. Leukemia & lymphoma. 26(1-2). 57–65. 22 indexed citations

14.

Gaynon, Paul S., Peter G. Steinherz, W. Archie Bleyer, et al.. (1993). Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106.. Journal of Clinical Oncology. 11(11). 2234–2242. 94 indexed citations

15.

Steinherz, Peter G., et al.. (1991). Association of delivered drug dose and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features. Medical and Pediatric Oncology. 19(4). 221–227. 11 indexed citations

16.

Phillips∥, Peter C., James R. Moeller, John J. Sidtis, et al.. (1991). Abnormal cerebral glucose metabolism in long‐term survivors of childhood acute lymphocytic leukemia. Annals of Neurology. 29(3). 263–271. 35 indexed citations

17.

Steinherz, Peter G., Paul A. Meyers, Norma Wollner, Arlene Redner, & Charlotte Tan. (1989). Reinduction therapy for advanced or refractory acute lymphoblastic leukemia of childhood. Cancer. 63(8). 1472–1476. 15 indexed citations

18.

Ott, Nancy L., Norma K.C. Ramsay, John R. Priest, et al.. (1988). Sequelae of Thrombotic or Hemorrhagic Complications Following L-Asparaginase Therapy for Childhood Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 10(3). 191–195. 31 indexed citations

19.

Bussel, James B., Peter G. Steinherz, Denis R. Miller, & Margaret W. Hilgartner. (1984). A heparin‐like anticoagulant in an 8‐month‐old boy with acute monoblastic leukemia. American Journal of Hematology. 16(1). 83–90. 27 indexed citations

20.

Tan, Carlyn, R. Gralla, Peter G. Steinherz, & Charles W. Young. (1978). Phase I study of chlorozotocin. Proceedings of the American Association for Cancer Research. 19. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact